To investigate the role of FOXA2 in RCC development, we knocked down FOXA2 in two RCC cancer lines, A498 and 769P, by two independent interference RNAs, which reduced FOXA2 expression to less than 80% of the scrambled negative controls (NC) (Fig. 2A). The gene discussed is FOXA2; the disease is cancer.